Rohinton P Edalji

Title: Rohinton P Edalji: Innovator in Recombinant Protein Technology

Introduction

Rohinton P Edalji is a notable inventor based in Wadsworth, IL (US). He has made significant contributions to the field of biotechnology, particularly in the development of recombinant forms of human beta-amyloid protein. His work has implications for therapeutic applications and diagnostic assays.

Latest Patents

Edalji holds a patent titled "Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins." This invention focuses on the cloning, expression, and isolation of recombinant forms of beta-amyloid protein. It also details methods for utilizing this recombinant protein in the production of therapeutic antibodies, the identification of therapeutic small molecules, and the performance of diagnostic assays. He has 1 patent to his name.

Career Highlights

Throughout his career, Edalji has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Abbott Laboratories Corporation and Abbott GmbH & Co. KG. His experience in these organizations has allowed him to contribute to significant advancements in medical technology.

Collaborations

Edalji has collaborated with various professionals in his field, including Boris Labkovsky and Stefan Barghorn. These partnerships have enhanced his research and development efforts, leading to innovative solutions in biotechnology.

Conclusion

Rohinton P Edalji is a distinguished inventor whose work in recombinant protein technology has the potential to impact therapeutic and diagnostic fields significantly. His contributions continue to pave the way for advancements in biotechnology.